Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Oral-Lyn – Oral Spray Formulation of Human Insulin for Types 1 and 2 Diabetes

Drug (brand / generic)

Oral-Lyn

Company / licensee

Generex Biotechnology

Therapy class

Insulins

Product description

Oral spray formulation of human insulin

Current indication

Type 2 diabetic patients

Market sector

Diabetes

Development status

Approved in Ecuador, India, Lebanon and Algeria. Phase III in Europe and North America
Expand

Go Top